nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.10.2014 | Original Article

Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia

verfasst von: N. H. Amr, A. Y. Ahmed, Y. A. Ibrahim

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients with congenital adrenal hyperplasia (CAH) are at increased risk for cardiovascular disease due to many factors. The aim of this study is to investigate the presence of dyslipidemia, insulin resistance, and subclinical atherosclerosis as indicated by carotid intima media thickness in children with congenital adrenal hyperplasia.

Methods

Thirty-two children with congenital adrenal hyperplasia (3–17 years) were compared with 32 healthy controls. All underwent anthropometric evaluation, measurement of fasting lipids, glucose, insulin, oral glucose tolerance test (OGTT), homeostasis model assessment for insulin resistance (HOMA-IR), and carotid intima media thickness (CIMT).

Results

Fasting glucose, glucose at 30, 60, 90, and 120 min during OGTT were significantly higher in patients. HOMA-IR was also significantly higher in patients (p = 0.036). Patients had significantly higher CIMT (p = 0.003), and higher systolic blood pressure. (p = 0.04). No significant difference existed in lipid profile. Both systolic and diastolic blood pressures correlated with treatment duration (p = 0.002, p = 0.043, respectively).

Conclusion

Children with CAH are at increased risk of insulin resistance, glucose intolerance, early atherosclerosis, and cardiovascular disease. Screening of these patients at an early age is recommended.

Charmandari E, Chrousos GP (2006) Metabolic syndrome manifestations in classic congenital adrenal hyperplasia. Do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Ann NY Acad Sci 1083:37–53PubMedCrossRef

Zimmermann A, Grigorescu-Sido P, AlKhzouz C, Patberg K, Bucerzan S, Schulze E, Zimmermann T, Rossmann H, Geis HC, Lackner KJ, Weber MM (2010) Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res Paediatr 74:41–49PubMedCrossRef

Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349:776–788PubMedCrossRef

White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245–291PubMed

Charmandari E, Hindmarsh PC, Johnston A, Brook CG (2001) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. J Clin Endocrinol Metab 86:2701–2708PubMedCrossRef

Van Wyk JJ, Gunther DF, Ritzen EM, Wedell A, Cutler GB Jr, Migeon CJ, New MI (1996) The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 81:3180–3190PubMed

Völkl TM, Simm S, Beier C, Dorr HG (2006) Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 117:e98–e105PubMedCrossRef

Charmandari E, Weise M, Bornstein S, Eisenhofer G, Keil MF, Chrousis GP, Merke DP (2002) Children with classic congenital hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 87:2114–2120PubMedCrossRef

Yazıcı D, Yavuz D, Öğünç AV, Sirikçi Ö, Toprak A, Deyneli O, Akalın S (2012) Serum adipokine levels in type 1 diabetic patients: association with carotid intima media thickness. Metab Syndr Relat Disord 10(1):26–31PubMedCrossRef

10.

Cheng KS, Mikhaulidis DP, Hamilton G, Seifalian AM (2002) A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res 54:528–538PubMedCrossRef

11.

Sempe M, Pedrong G, Roy-Ternot NP (1979) Auxologie le methods et sequences. Theraplix, Paris

12.

Cole TJ, Freeman JV, Preece MA (1995) Body mass index reference curves for the UK 1990. Arch Dis Child 73(1):25–29PubMedCrossRefPubMedCentral

13.

Tanner JM (1962) Growth at adolescence. Blackwell Scientific Publications, Oxford. http://www.epi.umn.edu/let/pubs/img/adol_ch1.pdf. Accessed 10 Apr 2013

14.

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th report):555–576

15.

Blumenthal S, Epps RP, Heavenrich R, Lauer RM, Lieberman E, Mirkin B, Mitchell SC, Boyar Naito V, O’Hare D, McFate Smith W, Tarazi RC, Upson D (1977) Report of the task force on blood pressure control in children. Pediatrics 59(2 Suppl):I–II, 797–820

16.

Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502PubMed

17.

Zimmet P, Alberti K, George MM, Tajima M, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S, IDF Consensus Group (2007) The metabolic syndrome in children and adolescents: an IDF consensus report. Pediatr Diabetes 8:299–306PubMedCrossRef

18.

World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Genebra: report of WHO a consultation. Part 1: diagnosis and classification of diabetes mellitus

19.

Mattews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRef

20.

Atabek ME, Pirgon O (2007) Assessment of insulin sensitivity from measurements in fasting state and during an oral glucose tolerance test in obese children. J Pediatr Endocrinol Metab 20(2):187–195

21.

Greulich GWW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2 edn. Stanford University Press, Stanford

22.

Subbarayan A, Dattani MT, Peters CJ, Hindmarsh PC (2014) Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 80:471–477CrossRef

23.

Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115:459–467PubMedCrossRef

24.

Mooij CF, Kroese JM, Claahsen-van der Grinten HL, Tack CJ, Hermus Ad RMM (2010) Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia? Clin Endocrinol 73:137–146

25.

Harrington J, Peña AS, Gent R, Hirte C, Couper J (2012) Adolescents with congenital adrenal hyperplasia because of 21-hydroxylase deficiency have vascular dysfunction. Clin Endocrinol (Oxf) 76(6):837–842CrossRef

26.

Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjold A, Hagenfeldt K, Thoren M (2007) Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:110–116PubMedCrossRef

27.

Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ (2010) Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 95:5110–5121PubMedCrossRefPubMedCentral

28.

Finkielstain GP, Kim MS, Sinaii N, Nishitani M, Van Ryzin C, Hill SC, Reynolds JC, Hanna RM, Merke DP (2012) Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 97:4429–4438PubMedCrossRefPubMedCentral

29.

Craig R, Mindell J (eds) (2011) Health survey for England 2010. NHS Information Centre, London

30.

Stikkelbroeck NM, Oyen WJ, van der Wilt GJ, Hermus Ad RMM, Otten BJ (2003) Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 88:1036–1042PubMedCrossRef

31.

Völkl TMK, Simm D, Dotsch J, Rascher W, Dorr HG (2006) Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4888–4895PubMedCrossRef

32.

Reisch N, Arlt W, Krone N (2011) Health problems in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res Paediatr 76:73–85PubMedCrossRef

33.

Roche EF, Charmandari E, Dattani MT, Hindmarsh PC (2003) Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clin Endocrinol 58:589–596CrossRef

34.

de Silva KS, Kanumakala S, Brown JJ, Jones CL, Warne GL (2004) 24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia––a preliminary report. J Pediatr Endocrinol Metab 17:1089–1095PubMed

35.

Nebesio TD, Eugster EA (2006) Observation of hypertension in children with 21-hydroxylase deficiency: a preliminary report. Endocrine 30:279–282PubMedCrossRef

36.

Williams RM, Deeb A, Ong KK, Bich W, Murgatroyd PR, Hughes IA, Acerini CL (2010) Insulin sensitivity and body composition in children with classical and nonclassical congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 72:155–160CrossRef

37.

Paula FJ, Gouveia GM, Piccinato CE, Moreira AC, Foss MC (1994) Androgen-related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia. Horm Metab Res 26:552–556PubMedCrossRef

38.

Mnif MF, Kamoun M, Mnif F, Charfi N, Ben Naceur B, Kallel N, Rekik N, Mnif Z, Sfar MH, Sfar MT, Hachicha M, Abid M (2012) Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Indian J Endocrinol Metab 16(6):939–946PubMedCrossRefPubMedCentral

39.

Vo¨lkl TMK, Simm D, Ko¨rner A, Rascher W, Kiess W, Kratzsch J, Dorr HJ (2009) Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency? Eur J Endocrinol 160:239–247CrossRef

40.

Bo¨ttner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M, Kiess W (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89:4053–4061CrossRef

41.

Fallo F, Scarda A, Sonino N, Paoletta A, Boscaro M, Pagano C, Federspil G, Vettor R (2004) Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing’s syndrome. Eur J Endocrinol 150:339–344PubMedCrossRef

42.

Degawa-Yamauchi M, Moss KA, Bovenkerk JE, Shankar SS, Morrison CL, Lelliott CJ, Vidal-Puig A, Jones R, Considine RV (2005) Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 13:662–669PubMedCrossRef

43.

Vo¨lkl TMK, Simm D, Ko¨rner A, Kiess W, Kratzsch J, Dorr HG (2009) Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Acta Paediatr 98:885–891CrossRef

44.

Sartorato P, Zulian E, Benedini S, Mariniello B, Schiavi F, Bilora F, Pozzan G, Greggio N, Pagnan A, Mantero F, Scaroni C (2007) Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:1015–1018PubMedCrossRef

45.

Bachelot A, Plu-Bureau G, Thibaud E, Laborde K, Pinto G, Samara D, Nihoul-Fekete C, Kuttenn F, Polak M, Touraine P (2007) Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 67:268–276PubMedCrossRef

46.

Falhammar H, Filipsson Nyström H, Wedell A, Thorén M (2011) Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 164(2):285–293PubMedCrossRef

47.

Botero D, Arango A, Danon M, Lifshitz F (2000) Lipid profile in congenital adrenal hyperplasia. Metabolism 49:790–793PubMedCrossRef

Titel: Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia
verfasst von: N. H. Amr
A. Y. Ahmed
Y. A. Ibrahim
Publikationsdatum: 01.10.2014
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 10/2014
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-014-0148-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2014

Relationships between serum omentin-1, body fat mass and bone mineral density in healthy Chinese male adults in Changsha area

The impact of real practice inappropriateness and devices’ inefficiency to variability in growth hormone consumption

BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency

A novel mutation in autoimmune regulator gene causes autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline

A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism